Retracted: microRNA-495 alleviates endothelial cell inflammatory injury in coronary heart disease via blockade of the NF-κB pathway by targeting RALB.

Author unknown

Open source

DOI
10.1002/jcp.29679
Published
2022 Mar
Container
Journal of cellular physiology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcp.29679,
  title = {Retracted: microRNA-495 alleviates endothelial cell inflammatory injury in coronary heart disease via blockade of the NF-κB pathway by targeting RALB.},
  year = {2022},
  journal = {Journal of cellular physiology},
  doi = {10.1002/jcp.29679},
  url = {https://doi.org/10.1002/jcp.29679}
}

RIS

TY  - JOUR
TI  - Retracted: microRNA-495 alleviates endothelial cell inflammatory injury in coronary heart disease via blockade of the NF-κB pathway by targeting RALB.
PY  - 2022
JO  - Journal of cellular physiology
DO  - 10.1002/jcp.29679
UR  - https://doi.org/10.1002/jcp.29679
ER  - 

APA

Retracted: microRNA-495 alleviates endothelial cell inflammatory injury in coronary heart disease via blockade of the NF-κB pathway by targeting RALB.. (2022). Journal of cellular physiology. https://doi.org/10.1002/jcp.29679

Source records